C.J.M. Lips

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

Laura S. Schmidt, Fuh-Mei Duh, Fan Chen et al. · Nature Genetics · 1997 · 1.5K citations

Medicine, Genetics, Oncology +17

Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International <i>RET</i> Mutation Consortium

Lois M. Mulligan, Deborah J. Marsh, Bruce G. Robinson et al. · Journal of Internal Medicine · 1995 · 272 citations

Life Sciences, Endocrinology, Genetics +17

A Phase II Trial of Imatinib Therapy for Metastatic Medullary Thyroid Carcinoma

Jan Willem B. de Groot, Bernard A. Zonnenberg, Patricia Quarles van Ufford-Mannesse et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 180 citations

Medicine, Oncology, Pharmacology +12

Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy

Boudewijn Brans, A. Hoekstra, Pierre Zelissen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 76 citations

Medicine, Endocrinology, Oncology +16

Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases.

Robert M.W. Hofstra, Tineke Stelwagen, Rein P. Stulp et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 76 citations

Medicine, Genetics, Oncology +17